Conor Lundergan

Ellicott City, MD (USA)
Role(s):
Founder/Owner/Principal

CapGen Sciences, Inc

Location: Ellicott City
Industry: Bio-Technology
Year Founded: 2004
Number Employees: 1-10 people
Description: Biotechnology R&D company which has developed medical diagnostic test in the area of "personalized medicine" i.e., genomics, which directs best treatment option and outcome for patients with cardiovascular disease. Market (US) is 6,000,000 tests per year performed at a centralized testing facility. Similar size market in Europe. We have Strategic Partner who is the major manufacturer of only FDA approved genomic platform used for our proprietary test & Agreement is in place which effectively blocks entry onto market of any competitor. Patent has been submitted to PTO. Require equity investment for Phase 3 FDA approved Validation Study (18 months for completion).